News and Announcements
Proteomics Targets Gastro-Causing Parasite
- Published October 20, 2016 11:16AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
20th October 2016, ASX Announcement
Perth life sciences company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) has successfully applied its biomarker discovery platform Promarker to the parasite Giardia.
- PILL maps samples from the gastro-causing parasite Giardia.
- Giardiasis is one of the most common waterborne diseases worldwide.
- Secures commercial funding and Federal Entrepreneurs’ Programme grant to help commercialise the test.
- PILL to receive a royalty stream from net sales for any diagnostic test.
PILL used the company’s proprietary technology to map samples of the gastro-causing parasite, searching for protein ‘fingerprints’ that can distinguish between different strains.
The proof-of-concept study was conducted in collaboration with Murdoch University and on a feefor-service basis with a leading US veterinary company. This collaboration will now be extended with the aim to develop a commercial diagnostic test for Giardia, and a licence agreement is in place to ensure PILL receives a royalty stream from sales of any test.
To view the full announcement, please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
